Company Monitoring Page for Sanofi

latest headlines for company on cafepharma

Sanofi to chop 100 US jobs in oncology R&D, Genzyme reorg
BioPharma Dive
Wed, 02/11/15 - 05:41 pm
Tags:
Sanofi, reorganization, layoffs, R&D, Genzyme, oncology
Regeneron says its allergy drug could be as big as PCSK9 blockers
Fierce Pharma
Wed, 02/11/15 - 05:40 pm
Tags:
Regeneron, allergies, Sanofi, dupilumab
Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager
Fierce Biotech
Wed, 02/11/15 - 09:02 am
Tags:
Sanofi, R&D, gene therapy, Voyager Therapeutics
Merck and Novo join an open-source R&D club with Amgen, Sanofi and Ono
Fierce Biotech
Tue, 02/10/15 - 10:40 am
Tags:
R&D, Merck, Novo Nordisk, Amgen, Sanofi, Ono Pharmaceutical
Sanofi undertakes major sales reorg of US diabetes business
BioPharma Dive
Tue, 02/10/15 - 10:39 am
Tags:
Sanofi, Novo Nordisk, diabetes, reorganization
On MannKind, Diabetics Have One Up On Wall Street
Forbes
Sun, 02/8/15 - 09:58 am
Tags:
MannKind, Afrezza, Sanofi, diabetes
Sanofi's finally going to name a new CEO, chairman says
Fierce Biotech
Thu, 02/5/15 - 06:23 pm
Tags:
Sanofi
What MannKind Investors Can Learn From The Sanofi Conference Call
Seeking Alpha
Thu, 02/5/15 - 05:11 pm
Tags:
MannKind, Sanofi, Afrezza, diabetes, inhaled insulin
Sanofi profit soars on lower Lemtrada charge
Yahoo/AP
Thu, 02/5/15 - 09:06 am
Tags:
Sanofi, earnings
How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars
Seeking Alpha
Wed, 02/4/15 - 01:18 pm
Tags:
Regeneron, Sanofi, Amgen, drug pricing
Can Sanofi's kinder, gentler, inhalable Afrezza win reluctant patients over to insulin?
Fierce Pharma Marketing
Wed, 02/4/15 - 10:26 am
Tags:
Sanofi, Afrezza, inhaled insulin, insulin, diabetes, MannKind
Sanofi SA (ADR) (SNY) Launches Inhaled Insulin Afrezza
Bidness Etc.
Tue, 02/3/15 - 08:59 am
Tags:
Sanofi, inhaled insulin, Afrezza, diabetes, insulin, drug launches, MannKind
Sanofi SA (SNY) Q4 Earnings Preview
Bidness Etc.
Mon, 02/2/15 - 07:49 am
Tags:
Sanofi, earnings
Drug Firm Sanofi Can't Find A CEO
Business Insider
Fri, 01/30/15 - 09:13 am
Tags:
Sanofi, Pharma CEOs
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Tags:
Sanofi, Regeneron, Amgen, alirocumab, evolocumab, PCSK9 inhibitors
Ex-Sanofi chief Viehbacher makes a $5M-plus severance deal
Fierce Pharma
Fri, 01/23/15 - 08:27 am
Tags:
Sanofi, Chris Viehbacher, executive pay
Law firms trolling for shareholders to sue Sanofi over alleged kickbacks
Fierce Pharma Marketing
Wed, 01/21/15 - 10:20 am
Tags:
Sanofi, whistleblower lawsuits, shareholders
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Tags:
Harvoni, Viekira Pak, Gilead Sciences, AbbVie, alirocumab, evolocumab, Amgen, Regeneron, Sanofi, Opdivo, Keytruda, Merck, Bristol-Myers Squibb, Novartis, CTL019, Zarxio, Pfizer, palbociclib, Saxenda, Trulicity, Afrezza, MannKind, Eli Lilly, Novo Nordisk, LCZ696, Toujeo, Breo Ellipta, GED-0301, Celgene, BiogenIdec
Sanofi, BI Enter Manufacturing Collaboration for Biologics
Drug Discovery and Development
Mon, 01/19/15 - 11:57 am
Tags:
Sanofi, Boehringer Ingelheim, R&D, biologics
Why The New MannKind Management Could Focus On R&D, Not A Potential Sanofi Merger
Yahoo/Benzinga
Mon, 01/12/15 - 07:30 pm
Tags:
MannKind, R&D, Afrezza, diabetes, M&A, Sanofi

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.